Transition from compensated to decompensated cardiac hypertrophy

Heart Failure Reviews

Volumn 4, Issue 4, 1999, Pages 379-388

  Sasayama, Shigetake ^a,b   Kihara, Yasuki ^a   Matsumori, Akira ^a   Hasegawa, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Beta adrenergic receptors; Calcium transient; Cytokines; Endothelin; Myocardial oxygen consumption; Sarcoplasmic reticulum

Indexed keywords

BETA ADRENERGIC RECEPTOR; BOSENTAN; CALCIUM ION; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; INTERLEUKIN 1BETA; MESSENGER RNA;

CONGESTIVE HEART FAILURE; CYTOKINE RELEASE; DISEASE COURSE; DISEASE MODEL; EXCITATION CONTRACTION COUPLING; HEART CONTRACTION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE OXYGEN CONSUMPTION; HEART STRESS; NONHUMAN; RAT; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SYRIAN HAMSTER;

EID: 0033503408     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009807804152     Document Type: Review

References (79)

1. Spann JF, Buccino RA, Sonnenblick EH, Braunwald E. Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 1967;21:341-354.
2. Williams JF, Potter RD. Normal contractile state of hypertrophied myocardium after pulmonary artery constriction in the cat. J Clin Invest 1974;54:1266-1274.
3. Sasayama S, Franklin D, Ross J Jr. Hyperfunction with normal inotropic state of the hypertrophied left ventricle. Am J Physiol 1977;232:H418-H425.
4. Takahashi M, Sasayama S, Kawai C, Kotoura H. Contractile performance of the hypertrophied ventricle in patients with systemic hypertension. Circulation 1980;62:116-126.
5. Flint A. A Practical Treatise on the Diagnosis, Pathology, and Treatment of Diseases of the Heart, 2nd ed. Philadelphia: HC Lea, 1870:33.
6. Osler W. The Principles and Practice of Medicine. New York: Appleton & Co, 1892:634.
7. Meerson FZ. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 1963;25(Suppl II):1-163.
8. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-3046.
9. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 1990;85:305-309.
10. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 1991;3:1866-1872.
11. Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 1992;71:18-26.
12. Bristow MR, Minobe W, Raynolds MV, Port JD, Rasmussen R, Ray PE, Feldman AM. Reduced β 1-receptor mRNA abundance in the failing human heart. J Clin Invest 1993;92:2737-2745.
13. Hajjar RJ, Gwathmey JK. Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart. Circulation 1992;86:1819-1826.
14. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor- a and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-711.
15. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patiensts with terminal heart failure. Circulation 1992;85: 1046-1055.
16. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 1994;90:653-657.
17. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
18. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-1094.
19. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 1994;267:H2471-H2482.
20. Inoko M, Kihara Y, Sasayama S. Neurohumoral factors during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats. Biochem Biophys Res Commun 1995;206:814-820.
21. Rapp TP, Wang SM, Dene H. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989;243:542-544.
22. Morii I, Kihara Y, Inoko M, Sasayama S. Myocardial contractile efficiency and oxygen cost of contractility are preserved during transition from compensated hypertrophy to failure in rats with salt-sensitive hypertension. Hypertension 1998;31:949-960.
23. Suga H. Ventricular energetics. Physiol Rev 1990;70: 247-277.
24. Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE. Antibody-mediated imbalance of myocardial energy metabolism. A causal factors of cardiac failure? Circ Res 1995;76:64-72.
25. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ Res 1996;78:893-902.
26. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 1998;82:898-907.
27. Kameyama T, Chen Z, Bell SP, VanBuren P, Maughan D, LeWinter MM. Mechanoenergetic alterations during the transition from cardiac hypertrophy to failure in Dahl salt-sensitive rats. Circulation 1998;98:2919-2929.
28. Cannell MB. New insights into cardiac excitation-contraction coupling in normal and hypertension/failure animal models. J Hum Hypertens 1997;11:555-558.
29. Bing OHL, Brooks WW, Conard CH, Sen S, Perreault CL, Morgan JP. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure. Circ Res 1991;68:1390-1400.
30. Saeki Y, Kurihara S, Hongo K, Tanaka E. Alterations in intracellular calcium and tension of activated ferret papillary muscle in response to step length changes. J Physiol 1993;463:291-306.
31. 2+ removal in hyperthyroid myocardium. Am J Physiol 1999;45:H289-H299.
32. Lakatta EG, Sollott SJ, Janczewski AM, Gambassi G, Silverman HS, Capogrossi MC, Danziger RS, Spurgeon HA. Mechanisms of relaxation: Perspectives from studies in single cardiac cells. In: Lorell BH, Grossman W, eds. Diastolic Relaxation of the Heart. Boston, Kluwer Academic Publishers, 1994:149-165.
33. Perreault CL, Bing OHL, Brooks WW, Ransil BJ, Morgan JP. Differential effects of cardiac hypertrophy and failure on right versus left ventricular calcium activation. Circ Res 1990;67:707-712.
34. Brooks WW, Bing OH, Litwin SE, Conrad CH, Morgan JP. Effects of treppe and calcium on intracellular calcium and function in the failing heart from the spontaneously hypertensive rat. Hypertension 1994;24:347-356.
35. Feldman MD, Copelas L, Gwathmey JK, Phillips R, Warren SE, Schoen FJ, Grossman W, Morgan JP. Deficient production of cyclic AMP: Pharmacologie evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 1987;75:331-339.
36. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homey CJ, Vatner SF, Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993;91:907-914.
37. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998;37:279-289.
38. Mittman C, Eschenhagen T, Scholz H. Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc Res 1998;39:267-275.
39. Eisner DA, Trafford AW, Diaz ME, Overend CL, O'Neill SC. The control of Ca release from the cardiac sarcoplasmic reticulum: Regulation versus autoregulation. Cardiovasc Res 1998;38:589-604.
40. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995;92:3220-3228.
41. Kihara Y, Ohkusa T, Iwanaga Y, Hayashida W, Matsuzaki M, Sasayama S. Calcium regulation and contraction of the left ventricular myocardium during the transition from established hypertrophy to failure in salt-sensitive rats with hypertension. J Mol Cell Cardiol 1998;30:A298.
42. Arai M, Tomaru K, Takizawa T, Sekiguchi K, Yokoyama T, Suzuki T, Nagai R. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits. J Mol Cell Cardiol 1998;30:243-254.
43. Lange LG, Schreiner GF. Immune cytokines and cardiac disease. Trends Cardiovasc Med 1992;2:145-151.
44. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
45. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-566.
46. Kubota T, McNamara DM, Wang JJ, et al., for the VEST Investigators for TNF Genotype Analysis. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. Circulation 1998;97:2499-2501.
47. MacGowan GA, Mann DL, Kormos RL, Feldman AM, Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 1997;79:1128-1131.
48. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1989;86:6753-6757.
49. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 1994;269:27580-27588.
50. Oyama J, Shimokawa H, Momii H, Cheng X, Fukuyama N, Arai Y, Egashira K, Nakazawa H, Takeshita A. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest 1998;101:2207-2214.
51. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-389.
52. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-a in the adult mammalian heart. J Clin Invest 1993;92:2303-2312.
53. Oral H, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-a in the adult mammalian cardiac myocyte. J Biol Chem 1997;272: 4836-4842.
54. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 1996;98: 2854-2865.
55. Shioi T, Matsumori A, Kihara Y, Inoko M, Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K, Sasayama S. Increased expression of interleukin-1 β and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ Res 1997;81:664-671.
56. Aukrust P, Ueland T, Müller F, Andreassen AK, NordØy I, Aas H, Kjekshus J, Simonsen S, FrØland SS, Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998;97: 1136-1143.
57. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Matsushima K, Sasayama S. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419-423.
58. Gawaz M, Neumann F-J, Dickfeld T, Koch W, Laugwitz K-L, Adelsberger H, Langenbrink K, Page S, Neumeier D, Schömig A, Brand K. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998;98:1164-1171.
59. Okada M, Matsumori A, Ono K, Furukawa Y, Shioi T, Iwasaki A, Matsushima K, Sasayama S. Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:894-901.
60. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998;82:532-539.
61. Vandenburgh HH. Mechanical forces and their second messengers in stimulating cell growth in vitro. Am J Physiol 1992;262:R350-R355.
62. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995;268:233-239.
63. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 1995;77:258-265.
64. Chen X-L, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 1998;83:952-959.
65. Bozkurt B, Kribbs SB, Clubb FJ, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-a promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998;97:1382-1391.
66. Haynes WG, Webb DJ. The endothelin family of peptides: Local hormones with diverse roles in health and disease? Clin Sci 1993;84:485-500.
67. Cody RJ, Hass GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-507.
68. Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation 1996;94:779-784.
69. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995;346:732-736.
70. Sakai S, Miyauchi T, Kobayashi M, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-355.
71. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249-252.
72. Kaddoura S, Firth JD, Boheler KR, Sugden PH, Poole-Wilson PA. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Circulation 1996;93: 2068-2079.
73. 1-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes. Circulation 1999;99:292-298.
74. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 1998;98:2065-2073
75. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990;166:324-329
76. Corder R, Carrier M, Khan N, Klemm P, Vane JR. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol 1995;26(Suppl 3): S56-S58.
77. Katabami T, Shimizu M, Okano K, Yano Y, Nemoto K, Ogura M, Tsukamoto T, Suzuki S, Ohira K, Yamada Y, Sekita N, Yoshida A, Someya K. Intracellular signal transduction for interleukin-1 beta-induced endothelin production in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1992;188:565-570.
78. Li JS, Schiffrin L. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25:495-500.
79. Hiroe M, Hirata Y, Fujita N, Umezawa S, Ito H, Tsujino M, Koike A, Nogami A, Takamoto T, Marumo F. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. Am Heart J 1991;68:1114-1115.